Our Editors cover the pharma waterfront, from late-stage drug development through the entire lifecycle—tracking regulatory approvals, payer negotiations, manufacturing, marketing, patent fights, government investigations and regulation, M&A deals and beyond.

Our Editors provide end-to-end coverage of biotech and medtech, from pre-clinical science through clinical testing and regulatory approval——and all the seed funding, venture capital, licensing deals, IPOs and M&A that happen along the way.

Fierce Healthcare provides critical business news to executives across the industry, including providers, payers and technology innovators.